NEW YORK (GenomeWeb News) – The National Institutes of Health plans to fund a network of centers that will use pharmacogenomics and more advanced genomic approaches to develop innovative methods for predicting drug responses.

The National Institute for General Medical Sciences will provide up to $1.8 million per year to each of these research centers, which beginning in 2015 will serve as anchors for the Pharmacogenomics Research Network, a program NIH has supported since 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.